"The FDA has approved or registered Sinovac's COVID-19 vaccine for conditional emergency use, effective Feb. 22," FDA deputy secretary-general Surachok Tangwiwat said, adding it was valid for one year.
BANGKOK: Thailand's Food and Drug Administration (FDA) has given emergency use authorisation for Sinovac Biotech's coronavirus vaccine, a senior official told Reuters on Monday.
"The FDA has approved or registered Sinovac's COVID-19 vaccine for conditional emergency use, effective Feb. 22," FDA deputy secretary-general Surachok Tangwiwat said, adding it was valid for one year.
Comments
Comments are closed.